Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey

BACKGROUND: The Icatibant Outcome Survey (IOS; NCT01034969) is a Shire‐sponsored, international, observational study monitoring the safety and effectiveness of icatibant, a bradykinin B2 receptor antagonist approved for the acute treatment of adults with hereditary angioedema with C1 inhibitor defic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Eur Acad Dermatol Venereol
Main Authors: Maurer, M., Bork, K., Martinez‐Saguer, I., Aygören‐Pürsün, E., Botha, J., Andresen, I., Magerl, M.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Autoimmune Diseases
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6587717/
https://ncbi.nlm.nih.gov/pubmed/30176179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.15232
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados